Tomas Tamosuitis
Overview
Explore the profile of Tomas Tamosuitis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kasputyte G, Jakisevaite M, Zurauskaite A, Karbonskiene A, Svagzdiene M, Kumpaitiene B, et al.
Anaesthesiol Intensive Ther
. 2024 Aug;
56(2):146-150.
PMID: 39166506
Introduction: Critical neurological conditions require urgent assessment and treatment. The quality of care and treatment provided during the transportation is important and related to the outcome of critically ill patients....
2.
Stakisaitis D, Kapocius L, Tatarunas V, Gecys D, Mickiene A, Tamosuitis T, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543303
The study presents data on the anti-inflammatory effects of a combination of sodium dichloroacetate and sodium valproate (DCA-VPA) on the expression of inflammation- and immune response-related genes in T lymphocytes...
3.
Pranskunas A, Zaveckiene J, Baranauskas T, Zakarauskaite B, Zykute D, Tamosuitis T
Intern Emerg Med
. 2023 Dec;
19(4):1081-1088.
PMID: 38105407
The chest X-ray (CXR) Brixia scoring system was developed exclusively for COVID-19 severity assessment. However, no association between the score and respiratory mechanics during mechanical ventilation has been examined. Our...
4.
Bajoriunaite A, Zaveckiene J, Usaite A, Dobiliene O, Tamosuitis T
Medicina (Kaunas)
. 2022 Nov;
58(11).
PMID: 36363472
Multisystem Inflammatory Syndrome (MIS) is a rare but increasingly recognized complication of SARS-CoV-2 infection, usually presenting 2 to 6 weeks after the onset of COVID-19 infection symptoms and affecting mainly...
5.
Deimantavicius M, Chaleckas E, Boere K, Putnynaite V, Tamosuitis T, Tamasauskas A, et al.
Sci Rep
. 2022 Oct;
12(1):17724.
PMID: 36272984
Optimal cerebral perfusion pressure (CPPopt)-targeted treatment of traumatic brain injury (TBI) patients requires 2-8 h multi-modal monitoring data accumulation to identify CPPopt value for individual patient. Minimizing the time required...
6.
Stakisaitis D, Kapocius L, Valanciute A, Balnyte I, Tamosuitis T, Vaitkevicius A, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625699
Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and...
7.
Establishing prognostic significance of hypoxia predictors in patients with acute cerebral pathology
Sarkulova Z, Tokshilykova A, Khamidulla A, Utepkaliyeva A, Ayaganov D, Sarkulov M, et al.
Neurol Res
. 2021 Nov;
44(4):362-370.
PMID: 34758699
Objectives: This research aims to study the prognostic role of serum S100 as a predictor of mortality in vascular and traumatic brain injuries. Methods: This prospective cohort study involved 219...
8.
Trilikauskiene A, Maraulaite I, Damanskyte D, Lukminaite D, Balciuniene N, Tamosuitis T
Medicina (Kaunas)
. 2020 Jul;
56(8).
PMID: 32707964
Organ shortage is considered to be a major limitation for increasing transplantation rates. Brain-dead donors (DBDs) are an important source of organs, but up to 50% of potential DBDs might...
9.
Rimaitis M, Bilskiene D, Tamosuitis T, Vilcinis R, Rimaitis K, Macas A
Med Sci Monit
. 2020 Jul;
26:e922879.
PMID: 32620738
BACKGROUND Coagulopathy (CP) is a modifiable factor linked with secondary brain damage and poor outcome of traumatic brain injury (TBI). A shift towards goal-directed coagulation management has been observed recently....
10.
Pranskunas A, Tamosuitis T, Balciuniene N, Damanskyte D, Sneider E, Vitkauskiene A, et al.
Microvasc Res
. 2018 Feb;
118:44-48.
PMID: 29462714
As of now the relationship between glycocalyx degradation and microcirculatory perfusion abnormalities in non-septic critical ill patients is unclear. In addition, conjunctival sidestream dark field-imaging for the purpose of glycocalyx...